88 results
8-K
EX-99.2
ELDN
Eledon Pharmaceuticals Inc
2 Nov 23
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
4:30pm
statements about the company’s future expectations, plans and prospects, including statements about its strategy, future operations, development of its … and strategy; the company’s intellectual property position and strategy; the company’s ability to identify additional products or product candidates
424B3
zlb28eq
8 Jun 23
Prospectus supplement
4:04pm
8-K
EX-99.2
y9b5vui0q
31 May 22
Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart
6:38am
8-K
EX-99.1
gzn1 cgp2kf1lfb
12 Aug 21
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
4:00pm